2003

Dec 18, 2003
Guidant Introduces New Vacuum Stabilizer System for Beating Heart Surgery

Off-Pump System Enhances Access and Visibility at Bypass Graft Connection Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Dec 17, 2003
Guidant Announces First Implant in SPIRIT FIRST Drug Eluting Stent Trial

Next-Generation Drug Eluting Stent Utilizes Guidant''s VISION Cobalt Chromium Stent Technology Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Dec 15, 2003
Guidant Announces Clinical Trial for Cardiac Resynchronization Therapy Defibrillator that Combines Treatment for both Heart Failure and Atrial Arrhythmias

Next Generation Device Designed to Address Common Co-morbidity for Heart Failure Patients Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Nov 25, 2003
Guidant Commends Passage of Medicare Reform Bill

Legislation Benefits Patients, Physicians and Medical Innovation Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Nov 19, 2003
Guidant Provides Overview of Drug Eluting Stent Program

Company Reiterates 2005 Introduction of First Drug Eluting Stent New York - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today is providing a...

Nov 19, 2003
Guidant Updates Investors During Annual Investor/Analyst Conference in New York

Company Reiterates Guidance for 2003; Previews 2004 Full-Year Revenue and Earnings New York - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will...

Nov 19, 2003
Guidant Broadens Advanced Patient Management Initiative with CardioMEMS Investment

New Investments and Sponsorships Bolster Guidant''s Commitment to Advanced Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment...

Nov 18, 2003
GE and Guidant Announce Unique Long-Term Relationship to Enhance and Improve Cardiovascular Patient Care

Strategic alliance allows for sharing of data and systems Milwaukee, Wis. and St. Paul, Minn. - GE Medical Systems, a division of the General Electric Company (NYSE: GE) and Guidant Corporation...

Nov 11, 2003
Guidant Announces U.S. Approval and Market Release of Novel Defibrillation Lead Family

RELIANCE G Leads are First to Feature Covering to Prevent Tissue Ingrowth Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Nov 10, 2003
Guidant Receives U.S. Approval of Most Advanced Pacemaker

NSIGNIA Ultra''s Unique Technology Enables Tailored Therapy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Nov 9, 2003
Guidant Receives Exclusive Expanded Indication for Heart Failure Treatment

MADIT II patients with heart failure now eligible for Cardiac Resynchronization Therapy Defibrillator Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the...

Nov 9, 2003
Guidant Announces Exclusive Sponsorship of MADIT-CRT Clinical Trial

Guidant''s Leadership in Heart Failure Therapy Continues with Landmark Study Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Nov 7, 2003
Guidant Announces Live Webcast of its Annual Investor/Analyst Conference

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will conduct a live webcast of its annual...

Oct 22, 2003
Guidant Announces U.S. Launch of Implantable Defibrillator Offering Optimal Combination of Size and Longevity

Latest Defibrillator Expands Successful Product Portfolio Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Oct 21, 2003
Guidant Announces Fourth Quarter Dividend

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s board of directors declared a fourth...

Oct 21, 2003
Guidant Licenses Innovative Tissue-Welding Technology for Cardiac Surgery

Agreement Reinforces Guidant''s Leadership in Endoscopic Cardiovascular Technologies Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Oct 16, 2003
Guidant Reports Record Third Quarter Sales of $938 million, 15 Percent Sales Growth

* Worldwide implantable defibrillator revenue of $385 million, up 48 percent * Worldwide stent revenue of $200 million, down 14 percent * Gross margin increases to 76.1 percent * Drug eluting...

Oct 9, 2003
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2003 earnings conference...

Oct 8, 2003
Guidant Initiates Voluntary Recall of 3.0 mm-Diameter MULTI-LINK VISION Coronary Stent System

Company Resumes Product Shipment with Food and Drug Administration Approval Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Oct 6, 2003
Guidant Announces European Approval and First Implant of Next Generation Heart Failure Therapy System

Cardiac Resynchronization Therapy Defibrillator Represents the World''s Thinnest, Most Advanced System Brussels, Belgium and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in...

Oct 2, 2003
Guidant Appoints Beverly H. Lorell, M.D., Vice President, Chief Medical and Technology Officer

New Position Will Lead Technology Development Strategy INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Beverly...

Sep 23, 2003
COMPANION Trial Results to be Announced During Late Breaking Scientific Session at the Heart Failure Society of America 7th Annual Scientific Meeting

Updated Landmark Heart Failure Trial Data Submitted to Peer-Reviewed Journal LAS VEGAS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Sep 23, 2003
Guidant Completes Enrollment in Clinical Investigation of New Therapy for Stroke Prevention

Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world...

Sep 19, 2003
Guidant's Institute for Therapy Advancement Europe Welcomes 5,000th Participant

Institute Demonstrates Guidant''s Leadership in Medical Education Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...

Sep 18, 2003
David E. Kandzari, M.D., Wins First Annual Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...

Sep 18, 2003
Guidant Announces Additional Findings of Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Study Shows Correlation Between Lipid-Rich Plaques and Heart Attacks in Cath Lab Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Sep 17, 2003
Guidant Reports Positive Results of Two Everolimus Eluting Coronary Stent Clinical Trials

FUTURE I and II Trials Utilize Everolimus with Bioabsorbable Polymer; Results Presented Today Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Sep 11, 2003
Guidant to Host Investor Briefing at Transcatheter Cardiovascular Therapeutics Meeting

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will host an investor briefing...

Sep 4, 2003
Guidant to Participate in Bear Stearns 16th Annual Healthcare Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Sep 2, 2003
Guidant Acquires Innovative Polymer Technology for Drug Eluting Stent Program

"Programmable" Polymer Capabilities Strengthen Guidant''s Development of Future Therapies for Coronary Artery Disease Indianapolis and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a...

Aug 26, 2003
Guidant Announces Share Repurchase at Mid-Quarter Conference Call Today

Company Outlines Progress Toward Drug Eluting Stent Milestones; Third Quarter and Full-Year 2003 Financial Guidance Affirmed Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...

Aug 20, 2003
Guidant Increases Investment in Innovator of Heart Surgery Devices

Additional Equity Investment Strengthens Guidant''s Commitment to the Development of Future Technologies for Heart Surgery Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in...

Aug 20, 2003
Guidant to Host Mid-Quarter Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call to provide an update on the...

Aug 19, 2003
Guidant Announces Third Quarter Dividend

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s board of directors declared a third...

Jul 21, 2003
Guidant Announces European Market Launch of its Most Advanced Pacemaker Line

Latest Addition to Pacemaker Portfolio Offers Improved Therapy Options While Maintaining Size and Longevity Brussels, Belgium and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...

Jul 18, 2003
Guidant Urges Conferees to Move Swiftly on Medicare Reform

Calls on Conference to Seize Historic Opportunity to Improve Quality and Expand Access Through Greater Choice, Competition and Innovation Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a...

Jul 17, 2003
Guidant Announces U.S. Approval of Newest Implantable Defibrillator for the Treatment of Irregular Heart Rhythms

World''s Smallest Dual Chamber System Offers Enhanced Therapies to Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...

Jul 17, 2003
Guidant Reports Record Sales of $945 Million in Second Quarter, Growth of 20 Percent

Worldwide implantable cardioverter defibrillator revenues of $377 million, up 50 percent; Worldwide stent revenue of $224 million, down 2 percent; Favorable product mix generates 75.4 percent...

Jul 16, 2003
Guidant Receives U.S. Approval for First Cobalt Chromium Coronary Stent System

Next-Generation Stent Design and Excellent Clinical Results Offer Expanded Treatment Options for Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Jul 14, 2003
New Study Shows Excellent Six-Month Results for Guidant's Market-Leading Small Vessel Stent

European Trial Demonstrates Low Restenosis Rate in Stenting of Small Vessels Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Jul 8, 2003
Guidant Announces U.S. Approval of Next Generation Heart Failure Therapy System

Cardiac Resynchronization Therapy-Defibrillator Represents the World''s Most Advanced System Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...

Jul 1, 2003
Guidant Enters Agreement with U.S. Department of Health and Human Services

Corporate Integrity Agreement Strengthens Guidant''s Commitment to Compliance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has entered into a corporate integrity...

Jul 1, 2003
Guidant Announces Live Webcast of its Second Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its second quarter 2003 earnings conference...

Jun 30, 2003
Guidant Reintroduces Innovative Cobalt Chromium Coronary Stent System in Europe

European Approval Received; New Technology''s Clinical Trial Demonstrated Excellent Results Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Jun 26, 2003
Guidant's Everolimus Eluting Stent Clinical Data Triggers Milestone Payment

Financial Guidance Updated Based on Strong Sales Companywide; Quarterly Dividend to be Paid June 30 INDIANAPOLIS - Guidant Corporation (NYSE: GDT) today announced that the company has made a $10...

Jun 16, 2003
Guidant to Discontinue Product for Treating Abdominal Aortic Aneurysms

No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced plans to...

Jun 16, 2003
Guidant to Complete Acquisition of Innovative Device for Treatment of Coronary Artery Disease

X Technologies Receives FX miniRAIL U.S. Food and Drug Administration Approval; Conditions of X Technologies Acquisition Fulfilled; Agreement Expected to Close This Quarter Indianapolis, Ind. -...

Jun 13, 2003
Guidant to Host Conference Call

Company''s Management to Provide Update on Recent Developments Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Jun 12, 2003
EndoVascular Technologies Enters into Settlement with U.S. Department of Justice

No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - EndoVascular Technologies, Inc. (EVT), a subsidiary of Guidant Corporation, today announced that it has entered into a...

Jun 10, 2003
Guidant Leads Clinical Investigation of New Therapy for Stroke Prevention

Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world...

Show 5102550100 per page
Top